Halozyme Therapeutics, Inc. (HALO) — Dilution Risk Analysis
Current Snapshot
Halozyme Therapeutics, Inc. (HALO) has a DilutionWatch score of 10/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 10/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 9, 3 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-08-11 | 0001662521-26-000002 |
| 4 | 2026-07-09 | 0001159036-26-000100 |
| 4 | 2026-07-02 | 0001159036-26-000094 |
| 4 | 2026-07-02 | 0001159036-26-000095 |
| 4 | 2026-06-30 | 0001159036-26-000082 |
| 4 | 2026-06-15 | 0001159036-26-000077 |
| 4 | 2026-04-07 | 0001159036-26-000048 |
| 4 | 2026-04-02 | 0001159036-26-000046 |
| 4 | 2026-04-02 | 0001159036-26-000047 |
| 3 | 2026-03-23 | 0001159036-26-000045 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 999 months | Source |
| Three-year share count growth | -14.08% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 10/10) Source
- Cash Runway
- 999 months Source
- Share Count Growth (3-Year)
- -14.08% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.